Traceable oncology research

Every question returns to its source.

Connect questions, oncology literature and clinical trials. Explore evidence, check its sources and build research you can trace.

Source-linked recordsNo advertising or audience analytics

Each colour is a cancer

Explore the thirteen colours in the legend below.

How it worksResearch tool · Not medical advice

00 / The ribbon

Each colour is a cancer

The ribbon is made of thirteen segments, one per cancer type in the catalog taxonomy. Select a segment or a legend entry to see them together.

Awareness colours are a reference, not a clinical classification.

01 / What you can do

A clearer path through the evidence.

Three workflows share one index and one rule: every claim points back to a record you can open.

Unmarked layered source sheets connected by fine threads

Ask with evidence

Pose a research question and receive a synthesis that cites study identifiers, separates evidence levels and states its limits.

Open Ask with evidence
Layered paper with opaque bands protecting selected information

Bring your sources

Add research publications or notes to a conversation. Prepared, de-identified material stays connected to the question it informs.

Open Bring your sources
An archival paper folio connected to separate source sheets

Write verified reports

Turn a run into a structured report whose findings are labelled as research patterns and linked to their sources.

Open Write verified reports

02 / How it works

From a question to a traceable report.

Four bounded stages. Each keeps the identifiers needed to return to the authoritative source.

  1. Research question

    Start with a question

    Describe what you want to investigate. The research model explores the catalog and consults authoritative sources when needed.

  2. Sources and context

    Connect the material

    Research documents and relevant publications are connected with their origin. Attachments are prepared and de-identified before use.

  3. Citation verification

    Inspect the evidence

    Read the cited studies, distinguish evidence types and inspect whether each source supports the claim. Uncertainty remains visible.

  4. Research report

    Keep the research traceable

    Create a report with research patterns, limitations and the reason each source was cited. Its identifier and file hash let you verify the document.

03 / The initiative

Knowledge grows when it stays connected.

Oncology research spans publications, trials and disciplines. OncoRadar helps researchers and clinicians navigate that literature while keeping each source, its context and its limitations within reach.

Our purpose is to support a careful reading of science: connect questions with original publications, make evidence inspectable and preserve a trace of the research. Scientific sources remain the authority, and professional judgment remains essential.

Principles

  • The original publication is the authority.
  • Evidence levels stay distinguishable.
  • No advertising or sale of personal data.

Operated by Celiums Solutions, LLC.

Individual paper strands woven into one shared structure

04 / Evidence and provenance

The source remains authoritative

Study records retain external identifiers, source URLs, versions, licences, editorial status and matched passages. Retrieval relevance is evidence about search—not evidence of clinical efficacy.

05 / Boundaries by design

What OncoRadar does not do

  • It does not give medical advice, diagnosis or treatment; its outputs are research patterns for professional verification.
  • It does not accept patient records or data for individual clinical care.
  • It does not equate ranking, semantic similarity or publication volume with evidence level.
  • It does not merge preprints, computational results, reviews and clinical trials into one score.

Give your next question a place to begin.

Use the catalog for explicit, paginated search; the assistant and workspace for reproducible research runs; the developer platform for stable REST and MCP contracts.